文献速递胸部肿瘤

非小细胞肺癌切除术后的外科医生质量与患者生存

Surgeon Quality and Patient Survival After Resection for Non-Small-Cell Lung Cancer.
PubMed 文献 · J Clin Oncol · 2023-06-02

研究基于2009至2021年39名外科医生实施的4082例切除手术,用切缘阳性、淋巴结未检查等指标将医生分为三个质量层级,发现低、中层医生的患者生存显著差于高层,调整具体诊疗过程后差异减弱。

要点

  • 低质量层级医生患者死亡风险高于高质量层级(HR 1.37,95%CI 1.10-1.72)。
  • 调整具体诊疗过程后,医生层级间生存差异减弱(HR 1.02,95%CI 0.8-1.3)。
  • 易获取的中间结局指标可用于分层医生表现并指导针对性改进。

核心结论

  • 易获取的中间结局指标可用于分层外科医生表现以进行针对性流程改进,可能减少患者生存差异。

研究设计与样本

  • 基于人群的基线手术切除队列衍生医生层面切点,应用于同一数据集后续队列,将医生按各指标分为1(<25百分位)、2(25-75百分位)、3(>75百分位)三档,总分4-6为低、7-9为中、10-12为高质量层级。
  • 2009至2021年39名外科医生共实施4082例切除手术,后续队列31名医生中5名为1层、5名为2层、21名为3层。
  • 采用卡方、Wilcoxon-Mann-Whitney和Kruskal-Wallis检验比较患者特征,Cox比例风险模型分析生存与医生层级关联。

主要发现

  • 1层和2层医生患者结局显著差于3层医生(HR 1.37,95%CI 1.10-1.72;HR 1.19,95%CI 1.00-1.43)。
  • 调整具体诊疗过程后,医生层级间生存差异减弱,调整后HR分别为1.02(95%CI 0.8-1.3)和0.93(95%CI 0.7-1.25)。

关键数值与推荐

  • 医生各指标分档:1(<25百分位)、2(25-75百分位)、3(>75百分位);总分4-6为低质量层级,7-9为中等,10-12为高质量。
  • 中间结局指标包括切缘阳性率、淋巴结未检查率、纵隔淋巴结未检查率和楔形切除率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The quality and outcomes of curative-intent lung cancer surgery vary in populations. Surgeons are key drivers of surgical quality. We examined the association between surgeon-level intermediate outcomes differences, patient survival differences, and potential mitigation by processes of care. PATIENTS AND METHODS: Using a baseline population-based surgical resection cohort, we derived surgeon-level cut points for rates of positive margins, nonexamination of lymph nodes, nonexamination of mediastinal lymph nodes, and wedge resections. Applying the baseline cut points to a subsequent cohort from the same population-based data set, we assign surgeons into three performance categories in reference to each metric: 1 (<25th percentile), 2 (25th-75th percentile), and 3 (>75th percentile). The sum of performance scores created three surgeon quality tiers: 1 (4-6, low), 2 (7-9, intermediate), and 3 (10-12, high). We used chi-squared, Wilcoxon-Mann-Whitney, and Kruskal-Wallis tests to compare patient characteristics between the baseline and subsequent cohorts and across surgeon tiers. We applied Cox proportional hazards models to examine the association between patient survival and surgeon performance tier, sequentially adjusting for clinical stage, patient characteristics, and four specific processes. RESULTS: From 2009 to 2021, 39 surgeons performed 4,082 resections across the baseline and subsequent cohorts. Among 31 subsequent cohort surgeons, five were tier 1, five were tier 2, and 21 were tier 3. Tier 1 and 2 surgeons had significantly worse outcomes than tier 3 surgeons (hazard ratio [HR], 1.37; 95% CI, 1.10 to 1.72 and 1.19; 95% CI, 1.00 to 1.43, respectively). Adjustment for specific processes mitigated the surgeon-tiered survival differences, with adjusted HRs of 1.02 (95% CI, 0.8 to 1.3) and 0.93 (95% CI, 0.7 to 1.25), respectively. CONCLUSION: Readily accessible intermediate outcomes metrics can be used to stratify surgeon performance for targeted process improvement, potentially reducing patient survival disparities.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Ray MA, Akinbobola O, Fehnel C, et al. Surgeon Quality and Patient Survival After Resection for Non-Small-Cell Lung Cancer. J Clin Oncol. 2023. PMID: 37267506. doi:10.1200/JCO.22.01971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。